Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial-Reference-Cited by-同舟云学术

Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial

Published:2023-07 Issue: Volume:258 Page:113400
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Juul Sandra E.^ORCID,Comstock Bryan A.,Cornet Marie-Coralie,Gonzalez Fernando F.,Mayock Dennis E.,Glass Hannah C.,Schreiber Michael D.,Heagerty Patrick J.,Wu Yvonne W.

Funder

National Institutes of Health

National Institute of Neurological Disorders and Stroke

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference25 articles.

1. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial;Eschbach;Ann Intern Med,1989

2. Erythropoietin after a century of research: younger than ever;Jelkmann;Eur J Haematol,2007

3. Cardiovascular effects of erythropoietin and anemia correction;Vaziri;Curr Opin Nephrol Hypertens,2001

4. The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events;Rosenzweig;J Pain Symptom Manage,2004

5. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis;Phrommintikul;Lancet,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pipeline to Neonatal Clinical Transformation;Clinics in Perinatology;2024-09

2. Early and extended erythropoietin monotherapy after hypoxic ischaemic encephalopathy: a multicentre double-blind pilot randomised controlled trial;Archives of Disease in Childhood - Fetal and Neonatal Edition;2024-05-10

3. Leflunomide Treatment Does Not Protect Neural Cells following Oxygen-Glucose Deprivation (OGD) In Vitro;Cells;2024-04-04

4. Emerging therapeutic strategies in hypoxic-ischemic encephalopathy: a focus on cognitive outcomes;Frontiers in Pharmacology;2024-02-26

5. Immune-Neurovascular Interactions in Experimental Perinatal and Childhood Arterial Ischemic Stroke;Stroke;2024-02